Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

2X2 Factorial Randomized Phase III Study Comparing Standard Versus Reduced Volume Radiotherapy With and Without Synchronous Chemotherapy in Muscle Invasive Bladder Cancer

NCT00024349 is registered in ClinicalTrials.gov with University Hospital Birmingham as lead sponsor.

NCT NCT00024349
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00024349 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
2X2 Factorial Randomized Phase III Study Comparing Standard Versus Reduced Volume Radiotherapy With and Without Synchronous Chemotherapy in Muscle Invasive Bladder Cancer
Lead sponsor
University Hospital Birmingham
Phase
Phase 3
Overall status
Completed
Start date
June 30, 2001
Completion date
April 30, 2012
Enrollment
350 (estimated)
Sites
27

Conditions

As the registry lists them; a condition with its own page is linked.

bladder cancer